{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:05:11Z","timestamp":1788818711998,"version":"build-2803163510"},"reference-count":136,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jns.2012.09.010","type":"journal-article","created":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T20:46:29Z","timestamp":1348865189000},"page":"25-32","source":"Crossref","is-referenced-by-count":26,"title":["Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease"],"prefix":"10.1016","volume":"323","author":[{"given":"Jerzy","family":"Leszek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sochocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazimierz","family":"G\u0105siorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2012.09.010_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuron.2006.09.016","article-title":"A hundred years of Alzheimer's disease research","volume":"52","author":"Hardy","year":"2006","journal-title":"Neuron"},{"issue":"Suppl. A","key":"10.1016\/j.jns.2012.09.010_bb0010","first-page":"1","article-title":"Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression","volume":"29","author":"Cacabelos","year":"2007","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.jns.2012.09.010_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.63.1.66","article-title":"Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease","volume":"63","author":"Starkstein","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2012.09.010_bb0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1533317506289260","article-title":"Systemic inflammatory markers and risk of dementia","volume":"21","author":"Dziedzic","year":"2006","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.jns.2012.09.010_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000289230","article-title":"Pharmacogenomic protocols in CNS disorders and dementia","volume":"7","author":"Cacabelos","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.jns.2012.09.010_bb0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1179\/016164104225017668","article-title":"Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease","volume":"26","author":"Kalback","year":"2004","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ceca.2005.06.021","article-title":"Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals","volume":"38","author":"Smith","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jns.2012.09.010_bb0040","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.brainresrev.2005.03.004","article-title":"Are mitochondria critical in the pathogenesis of Alzheimer's disease?","volume":"49","author":"Reddy","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.jns.2012.09.010_bb0045","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1089\/ars.2007.1754","article-title":"Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons","volume":"9","author":"Reddy","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jns.2012.09.010_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbadis.2006.11.001","article-title":"The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease","volume":"1772","author":"Nagy","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jns.2012.09.010_bb0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jns.2007.01.039","article-title":"Vascular oxidative stress in Alzheimer disease","volume":"257","author":"Zhu","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2012.09.010_bb0060","first-page":"1","article-title":"Post-stroke dementia: the contribution of thalamus and basal ganglia changes","volume":"12","author":"Lopes","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jns.2012.09.010_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-510X(02)00256-3","article-title":"Similarities between Alzheimer's disease and vascular dementia","volume":"203\u2013204","author":"Kalaria","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2012.09.010_bb0070","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1747-4949.2011.00666.x","article-title":"Can stroke cause neurodegenerative dementia?","volume":"6","author":"Cumming","year":"2011","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jns.2012.09.010_bb0075","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000080034","article-title":"Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial","volume":"18","author":"Engelberg","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jns.2012.09.010_bb0080","doi-asserted-by":"crossref","first-page":"18727","DOI":"10.1073\/pnas.0606298103","article-title":"Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression","volume":"103","author":"Sun","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2012.09.010_bb0085","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1179\/016164109X12445505689643","article-title":"Storke and dementia","volume":"31","author":"Pinkston","year":"2009","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0090","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archneur.60.12.1707","article-title":"Stroke and the risk of Alzheimer disease","volume":"60","author":"Honig","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2012.09.010_bb0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/STROKEAHA.107.495457","article-title":"Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension","volume":"39","author":"Dai","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2012.09.010_bb0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/brain\/awl385","article-title":"Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease","volume":"130","author":"Reed","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jns.2012.09.010_bb0105","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awh553","article-title":"Cerebral small-vessel disease and decline in information processing speed, executive function and memory","volume":"128","author":"Prins","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jns.2012.09.010_bb0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1179\/016164106X130362","article-title":"How do heart disease and stroke become risk factors for Alzheimer's disease?","volume":"28","author":"de la Torre","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/01.WNL.0000149641.55751.2E","article-title":"Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe","volume":"64","author":"den Heijer","year":"2005","journal-title":"Neurology"},{"issue":"11 Suppl. 1","key":"10.1016\/j.jns.2012.09.010_bb0120","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1161\/01.STR.0000143318.70292.47","article-title":"Risk factors for vascular dementia and Alzheimer disease","volume":"25","author":"Gorelick","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2012.09.010_bb0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainresrev.2004.12.014","article-title":"Interactions between Alzheimer's disease and cerebral ischemia-focus on inflammation","volume":"48","author":"Koistinaho","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.jns.2012.09.010_bb0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-2007-12406","article-title":"Cerebral ischemia and Alzheimer's disease: the expression of amyloid-beta and apolipoprotein E in human hippocampus","volume":"12","author":"Qi","year":"2007","journal-title":"J Alzheimers Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2012.09.010_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/S1041610203008950","article-title":"Vascular factors in Alzheimer's disease","volume":"15","author":"Kalaria","year":"2003","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jns.2012.09.010_bb0140","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(03)12521-4","article-title":"Alzheimer's disease and angiogenesis","volume":"361","author":"Vagnucci","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2012.09.010_bb0145","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","article-title":"Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline","volume":"62","author":"Thal","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jns.2012.09.010_bb0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1749-6632.2002.tb04817.x","article-title":"Vascular basis of Alzheimer's pathogenesis","volume":"977","author":"de la Torre","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2012.09.010_bb0155","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1161\/01.STR.0000179092.59909.42","article-title":"Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study","volume":"36","author":"van der Flier","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2012.09.010_bb0160","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.neurobiolaging.2005.10.004","article-title":"Vascular determinants of cholinerigic deficits in Alzheimer disease and vascular dementia","volume":"27","author":"Rom\u00e1n","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2012.09.010_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/156720507780362245","article-title":"Role of the blood\u2013brain barrier in the pathogenesis of Alzheimer's disease","volume":"4","author":"Deane","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0170","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jnnp.72.6.747","article-title":"Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss","volume":"72","author":"Kril","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2012.09.010_bb0175","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2007.02.021","article-title":"Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease","volume":"417","author":"Kitaguchi","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2012.09.010_bb0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1113\/expphysiol.2007.038752","article-title":"Genes endothelial function and cerebral small vessel disease in man","volume":"93","author":"Markus","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.jns.2012.09.010_bb0185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/appi.neuropsych.18.2.191","article-title":"White matter changes associated with psychotic symptoms in Alzheimer's disease patients","volume":"18","author":"Lee","year":"2006","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0190","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2006.05.016","article-title":"Microvascular injury and blood\u2013brain barrier leakage in Alzheimer's disease","volume":"28","author":"Zipser","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2012.09.010_bb0195","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.molmed.2005.10.008","article-title":"Cerebrovascular gene linked to Alzheimer's disease pathology","volume":"11","author":"de la Torre","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jns.2012.09.010_bb0200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.STR.0000054050.51530.76","article-title":"Converging pathogenic mechanisms in vascular and neurodegenerative dementia","volume":"34","author":"Iadecola","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2012.09.010_bb0205","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1212\/01.WNL.0000118211.78503.F5","article-title":"Cerebral infarctions and the likelihood dementia from Alzheimer disease pathology","volume":"62","author":"Schneider","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.09.010_bb0210","first-page":"73976","article-title":"Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease","volume":"3","author":"Rojo","year":"2006","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.jns.2012.09.010_bb0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia","volume":"4","author":"Qiu","year":"2005","journal-title":"Lancet Neurol"},{"issue":"11 Suppl. 1","key":"10.1016\/j.jns.2012.09.010_bb0220","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1161\/01.STR.0000143317.70478.b3","article-title":"Atherosclerosis of cerebral arteries in Alzheimer's disease","volume":"35","author":"Roher","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2012.09.010_bb0225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer's neurodegeneration","volume":"28","author":"Zlokovic","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0230","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1749-6632.2002.tb04830.x","article-title":"Vascular pathology in Alzheimer's disease","volume":"977","author":"Miyakawa","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2012.09.010_bb0235","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1023\/B:NERE.0000023612.66691.e6","article-title":"Links between the pathology of Alzheimer's disease and vascular dementia","volume":"29","author":"Sadowski","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0240","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","article-title":"Aggregation of vascular risk factors and risk of incident Alzheimer disease","volume":"65","author":"Luchsinger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.09.010_bb0245","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0755-4982(05)84049-7","article-title":"Hypertension and Alzheimer's disease","volume":"34","author":"Vogel","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.jns.2012.09.010_bb0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2002.tb04796.x","article-title":"Hypertension and related factors in the etiology of Alzheimer's disease","volume":"977","author":"Skoog","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2012.09.010_bb0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1076-7460.2007.06696.x","article-title":"Cardiovascular risk factors for Alzheimer's disease","volume":"16","author":"Rosendorff","year":"2007","journal-title":"Am J Geriatr Cardiol"},{"key":"10.1016\/j.jns.2012.09.010_bb0260","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1176\/appi.neuropsych.19.4.483","article-title":"Acute hypertensive crisis may be a risk factor for Alzheimer's disease induction and progression","volume":"19","author":"Gharibzadeh","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0265","first-page":"40","article-title":"The significance of arterial hypertension for the development of dementia","volume":"146","author":"Schrader","year":"2004","journal-title":"MMW Fortschr Med"},{"key":"10.1016\/j.jns.2012.09.010_bb0270","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1532-5415.2007.01378.x","article-title":"Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease?","volume":"55","author":"Dede","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jns.2012.09.010_bb0275","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000279520.59792.fe","article-title":"Vascular factors predict rate of progression in Alzheimer disease","volume":"69","author":"Mielke","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.09.010_bb0280","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1161\/01.STR.0000024523.82311.77","article-title":"Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer's disease","volume":"33","author":"Suter","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2012.09.010_bb0285","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.jcbfm.9600526","article-title":"Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study","volume":"28","author":"Vernooij","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jns.2012.09.010_bb0290","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0295","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2012.09.010_bb0300","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1073\/pnas.0608251104","article-title":"Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype","volume":"104","author":"Chow","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.jns.2012.09.010_bb0305","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ncb1819","article-title":"SRF and myocardin regulate LRP-mediated amyloid-\u03b2 clearance in brain vascular cells","volume":"11","author":"Bell","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jns.2012.09.010_bb0310","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nm1287","article-title":"Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease","volume":"11","author":"Wu","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2012.09.010_bb0315","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","article-title":"Clearance of amyloid-\u03b2 by circulating lipoprotein receptors","volume":"13","author":"Sagare","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2012.09.010_bb0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2012.09.010_bb0325","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0197-4580(01)00317-7","article-title":"Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood","volume":"23","author":"Monro","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2012.09.010_bb0330","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0005-2736(85)90179-8","article-title":"Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon","volume":"819","author":"Mann","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jns.2012.09.010_bb0335","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00006123-199704000-00027","article-title":"Cellular and molecular neurosurgery: pathways from concept to reality-part I: target disorders and concept approaches to gene therapy of the central nervous system","volume":"40","author":"Zlokovic","year":"1997","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jns.2012.09.010_bb0340","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1113\/expphysiol.2007.038729","article-title":"Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease","volume":"93","author":"Hamel","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.jns.2012.09.010_bb0345","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF03033159","article-title":"Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease","volume":"5","author":"Aliev","year":"2003","journal-title":"Neurotox Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0350","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1155\/S1110724303305029","article-title":"Hypoperfusion, mitochondria failure, oxidative stress and Alzheimer disease","volume":"3","author":"Aliev","year":"2003","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.jns.2012.09.010_bb0355","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1358\/dot.2002.38.5.677137","article-title":"Chronic cerebral hypoperfusion-related neuropathologic changes and compromised cognitive status: window of treatment","volume":"38","author":"Farkas","year":"2002","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.jns.2012.09.010_bb0360","first-page":"428","article-title":"The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease-facts and hypotheses","volume":"60","author":"Z\u00e1dori","year":"2007","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.jns.2012.09.010_bb0365","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/01.STR.0000221205.52404.5a","article-title":"Leukoaraiosis and ischemia: beyond the myth","volume":"37","author":"Munoz","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2012.09.010_bb0370","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.20516","article-title":"Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion?","volume":"57","author":"de la Torre","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2012.09.010_bb0375","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/01.STR.24.12.2121","article-title":"Altered gene expression in cerebral ischemia","volume":"24","author":"Kogure","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2012.09.010_bb0380","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1212\/01.wnl.0000210447.19748.0b","article-title":"Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers","volume":"66","author":"Beeri","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.09.010_bb0385","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1179\/016164106X130498","article-title":"Cardiac risk factors and potential treatments in Alzheimer's disease","volume":"28","author":"Bergmann","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0390","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JAD-2006-9209","article-title":"Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease","volume":"9","author":"de la Monte","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jns.2012.09.010_bb0395","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mito.2004.07.018","article-title":"Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease","volume":"4","author":"Aliev","year":"2004","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jns.2012.09.010_bb0400","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1074\/jbc.M608856200","article-title":"Hypoxia-inducible factor 1 alpha(HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation","volume":"15","author":"Zhang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2012.09.010_bb0405","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0709259105","article-title":"Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons","volume":"105","author":"Liang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2012.09.010_bb0410","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1567205043332036","article-title":"ROS effects on neurodegeneration in Alzheimer's disease and related disorders: on environmental stresses of ionizing radiation","volume":"1","author":"Manton","year":"2004","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0415","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.jnen.0000228136.58062.bf","article-title":"Involvement of oxidative stress in Alzheimer disease","volume":"65","author":"Nunomura","year":"2006","journal-title":"J Neuripathol Exp Neurol"},{"key":"10.1016\/j.jns.2012.09.010_bb0420","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2012.09.010_bb0425","first-page":"373","article-title":"Fluorescent advanced glycation endproducts in sera of Alzheimer's disease patients","author":"Leszek","year":"2005","journal-title":"Perspect Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0430","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1533317506291075","article-title":"Analysis of serum of patients with Alzheimer's disease for the level of advanced glycation end products","volume":"21","author":"Leszek","year":"2006","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.jns.2012.09.010_bb0435","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse Alzheimer disease","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2012.09.010_bb0440","doi-asserted-by":"crossref","first-page":"237A","DOI":"10.1016\/S0895-7061(02)02913-8","article-title":"Spotlighting hypertension and the brain: does controlling blood pressure reduce the risk of recurrent stroke and dementia? What we know about hypertension and dementia: mechanisms and interventions","volume":"15","author":"Gorelick","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jns.2012.09.010_bb0445","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1179\/016164106X130506","article-title":"Update on hypertension and Alzheimer's disease","volume":"28","author":"Skoog","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0450","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/156720205774322610","article-title":"Cerebrovascular damage as a cause for Alzheimer's disease","volume":"2","author":"Humpel","year":"2005","journal-title":"Curr Neurovasc Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0455","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0024-3205(02)02367-6","article-title":"Relationship between blood pressure and Alzheimer's disease in Linxian country, China","volume":"10","author":"Wu","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.jns.2012.09.010_bb0460","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident Alzheimer disease: the Cache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2012.09.010_bb0465","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/RLU.0b013e31815c4ff0","article-title":"Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease","volume":"33","author":"Matsuda","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jns.2012.09.010_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.7.1.1","article-title":"Pharmacological strategies for the prevention of Alzheimer's disease","volume":"7","author":"Doraiswamy","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jns.2012.09.010_bb0475","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.neurobiolaging.2010.10.021","article-title":"Toward an integrated genetic and epigenetic approach to Alzheimer's disease","volume":"32","author":"Mill","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2012.09.010_bb0480","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000323874","article-title":"Epigenetics: principles and practice","volume":"29","author":"Hamilton","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.jns.2012.09.010_bb0485","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuron.2011.05.019","article-title":"Epigenetic mechanisms in cognition","volume":"70","author":"Day","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2012.09.010_bb0490","doi-asserted-by":"crossref","first-page":"572495","DOI":"10.4061\/2011\/572495","article-title":"Potential peripheral biomarkers for the diagnosis of Alzheimer's disease","volume":"2011","author":"Patel","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.1016\/j.jns.2012.09.010_bb0495","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1476-5381.2009.00526.x","article-title":"Pharmacology of epigenetics in brain disorders","volume":"159","author":"Narayan","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jns.2012.09.010_bb0500","first-page":"9","article-title":"An epigenetic hypothesis of aging-related cognitive dysfunction","volume":"2","author":"Penner","year":"2010","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0505","doi-asserted-by":"crossref","first-page":"542","DOI":"10.5604\/17322693.956497","article-title":"Epigenetics and etiology of neurodegenerative diseases","volume":"65","author":"Gruber","year":"2011","journal-title":"Postepy Hig Med Dosw"},{"key":"10.1016\/j.jns.2012.09.010_bb0510","doi-asserted-by":"crossref","first-page":"e6617","DOI":"10.1371\/journal.pone.0006617","article-title":"Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease","volume":"4","author":"Mastroeni","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2012.09.010_bb0515","doi-asserted-by":"crossref","first-page":"e2698","DOI":"10.1371\/journal.pone.0002698","article-title":"Age specific epigenetic drift in late-onset Alzheimer's disease","volume":"3","author":"Wang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2012.09.010_bb0520","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pneurobio.2010.01.002","article-title":"Epigenetic regulation in the pathophysiology of Alzheimer's disease","volume":"90","author":"Chouliaras","year":"2010","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jns.2012.09.010_bb0525","doi-asserted-by":"crossref","first-page":"e22585","DOI":"10.1371\/journal.pone.0022585","article-title":"Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease","volume":"6","author":"Pietrzak","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2012.09.010_bb0530","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1523\/JNEUROSCI.3040-05.2005","article-title":"Ribosome dysfunction is an early event in Alzheimer's disease","volume":"25","author":"Ding","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0535","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.jnen.0000240474.27791.f3","article-title":"RNA in brain disease: no longer just \u201cthe messenger in the middle\u201d","volume":"66","author":"Nelson","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jns.2012.09.010_bb0540","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbr.2008.01.021","article-title":"Epigenetic codes in cognition and behaviour","volume":"192","author":"Gr\u00e4ff","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0545","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/ars.2010.3492","article-title":"The redox basis of epigenetic modifications: from mechanisms to functional consequences","volume":"15","author":"Cyr","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jns.2012.09.010_bb0550","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.freeradbiomed.2009.02.006","article-title":"Epigenetics, oxidative stress, and Alzheimer disease","volume":"46","author":"Zawia","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jns.2012.09.010_bb0555","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1523\/JNEUROSCI.3797-08.2008","article-title":"Epigenetics in the nervous system","volume":"28","author":"Jiang","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0560","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neurobiolaging.2011.02.024","article-title":"Epigenetic mechanisms in Alzheimer's disease: progress but much to do","volume":"32","author":"Balazs","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2012.09.010_bb0565","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18388\/abp.2011_2279","article-title":"Chromatin acetylation, \u03b2-amyloid precursor protein and its binding partner FE65 in DNA double strand break repair","volume":"58","author":"Szumiel","year":"2011","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.jns.2012.09.010_bb0570","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0575","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nlm.2011.04.002","article-title":"The role of histone acetylation in age-associated memory impairment and Alzheimer's disease","volume":"96","author":"Stilling","year":"2011","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.jns.2012.09.010_bb0580","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1028-4559(10)60099-X","article-title":"Alzheimer's disease: aging, insomnia and epigenetics","volume":"49","author":"Wu","year":"2010","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.jns.2012.09.010_bb0585","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2217\/epi.10.17","article-title":"Emerging themes in epigenetics: implications for understanding and treating nervous system disorders","volume":"2","author":"Qureshi","year":"2010","journal-title":"Epigenomics"},{"key":"10.1016\/j.jns.2012.09.010_bb0590","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer's disease correlates with increased BACE1\/\u03b2-secretase expression","volume":"105","author":"H\u1ebbbert","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.jns.2012.09.010_bb0595","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.1582-4934.2008.00400.x","article-title":"MicroRNAs: tiny regulators of synapse function in development and disease","volume":"12","author":"Bicker","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jns.2012.09.010_bb0600","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0605","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/138920209788185252","article-title":"MicroRNA: implications for Alzheimer disease and other human CNS disorders","volume":"10","author":"Maes","year":"2009","journal-title":"Curr Genomics"},{"key":"10.1016\/j.jns.2012.09.010_bb0610","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1523\/JNEUROSCI.4660-08.2009","article-title":"The cochaperone BAG2 sweeps paired helical filament-insoluble tau from microtubule","volume":"29","author":"Carrettiero","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0615","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/WNR.0b013e3280148e8b","article-title":"Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus","volume":"18","author":"Lukiw","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.jns.2012.09.010_bb0620","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jns.2012.09.010_bb0625","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","article-title":"MicroRNA regulation of Alzheimer's amyloid precursor protein expression","volume":"33","author":"H\u00e9bert","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2012.09.010_bb0630","doi-asserted-by":"crossref","first-page":"e11070","DOI":"10.1371\/journal.pone.0011070","article-title":"Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-\u03b2","volume":"5","author":"Schonrock","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2012.09.010_bb0635","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10522-008-9162-6","article-title":"Early-life events may trigger biochemical pathways for Alzheimer's disease: the \u201cLEARn\u201d model","volume":"9","author":"Lahiri","year":"2008","journal-title":"Biogerontology"},{"key":"10.1016\/j.jns.2012.09.010_bb0640","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.exger.2010.01.001","article-title":"The \u201cLEARn\u201d (latent early-life associated regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposed remedial steps","volume":"45","author":"Lahiri","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jns.2012.09.010_bb0645","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nature02661","article-title":"Gene regulation and DNA damage in the ageing human brain","volume":"429","author":"Lu","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jns.2012.09.010_bb0650","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1096\/fj.05-5091fje","article-title":"Exposure to lead and the developmental origin of oxidative DNA damage in aging brain","volume":"20","author":"Bolin","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.jns.2012.09.010_bb0655","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jnr.22074","article-title":"Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury-induced cytokine response after excitotoxic damage","volume":"87","author":"Campuzano","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2012.09.010_bb0660","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1113\/jphysiol.2009.176156","article-title":"Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome","volume":"587","author":"Plagemann","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.jns.2012.09.010_bb0665","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nn1276","article-title":"Epigenetic programming by maternal behavior","volume":"7","author":"Weaver","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jns.2012.09.010_bb0670","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrendo.2009.102","article-title":"Epigenetic mechanisms that underpin metabolic and cardiovascular diseases","volume":"5","author":"Gluckman","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jns.2012.09.010_bb0675","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.0803623105","article-title":"Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes","volume":"105","author":"Villeneuve","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.jns.2012.09.010_bb0680","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1084\/jem.20081188","article-title":"Transient high glucose causes persistent epigenetic changes and altered genome expression during subsequent normoglycemia","volume":"205","author":"El-Osta","year":"2008","journal-title":"J Exp Med"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12005023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12005023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T04:31:01Z","timestamp":1562214661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X12005023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":136,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0022510X12005023"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2012.09.010","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}